Posts With Tag NASDAQ HALO

Showing 1 - 2 of 2 Posts

Halozyme Therapeutics, Inc. 8-K Report: Key Insights from February 18, 2025 Filing

•

Form 8-K

•

2025-02-18

Last updated: 3 months ago

Halozyme Therapeutics, Inc. 8-K Report: Key Insights from February 18, 2025 Filing

Explore the latest 8-K filing from Halozyme Therapeutics, Inc. detailing significant events as of February 18, 2025. Stay informed on key updates for investors!

Halozyme Therapeutics biotechnology NASDAQ HALO current report 8-K investor relations

Halozyme Therapeutics 8-K Report: Key Insights on February 11, 2025 Events

•

Form 8-K

•

2025-02-13

Last updated: 3 months ago

Halozyme Therapeutics 8-K Report: Key Insights on February 11, 2025 Events

Explore Halozyme Therapeutics, Inc.'s 8-K filing from February 11, 2025, detailing crucial company updates, stock information, and significant events impacting shareholders.

Halozyme Therapeutics biotechnology NASDAQ HALO financial report 8-K XBRL reporting